U.S. Markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.3560%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.3207%)
     
  • USD/JPY

    104.7200
    -0.1200 (-0.1145%)
     
  • BTC-USD

    12,968.27
    +71.68 (+0.56%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Danaher (DHR) Raises Earnings & Sales Projections for Q4

Zacks Equity Research

Danaher Corporation DHR communicated yesterday that its fourth-quarter 2019 results will likely be better than previously expected. The announcement was made by Thomas P. Joyce, Jr., the company’s president and chief executive officer, at a healthcare conference.

The news seems to have lifted market sentiments, contributing to yesterday’s share price increase of 1.14%. The trading session ended, with the share price at $161.39.

Inside the Headlines

As noted, healthy performances of the Life Sciences and Diagnostics segments will likely drive fourth-quarter 2019 organic sales growth above the previous expectation of 4.5%. Also, the company expects the quarter’s adjusted earnings per share to either meet or exceed the higher end of $1.32-$1.35 mentioned earlier.

Notably, the Life Sciences and Diagnostics segments generated roughly 65% of Danaher’s total revenues of $5,037.3 million in the third quarter of 2019.

The Zacks Consensus Estimate for fourth-quarter revenues and earnings are pegged at $5.28 billion and $1.25 per share, suggesting declines of 1.6% and 2.3% from the year-ago reported figures, respectively. Also, in the past 60 days, earnings estimates of $1.25 have been revised down by 6%.

Notably, Danaher will release fourth-quarter 2019 results before the market opens on Jan 30, 2020.

Zacks Rank, Earnings Estimate Trend and Price Performance

With a market capitalization of $114.6 billion, the company currently carries a Zacks Rank #3 (Hold). Over the past 60 days, the Zacks Consensus Estimate for earnings has decreased 3.8% to $4.57 for 2019 and 3% to $5.41 for 2020.

Danaher Corporation Price and Consensus

 

Danaher Corporation Price and Consensus
Danaher Corporation Price and Consensus

Danaher Corporation price-consensus-chart | Danaher Corporation Quote

In the past three months, Danaher’s share price has increased 17.4% compared with the industry’s 15.3% growth.





Stocks to Consider

Some better-ranked stocks are DXP Enterprises, Inc DXPE, Cintas Corporation CTAS and Chart Industries, Inc GTLS. While DXP Enterprises currently sports a Zacks Rank #1 (Strong Buy), Cintas and Chart Industries carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

In the past 60 days, earnings estimates for these stocks have improved for the current year. Further, positive earnings surprise for the last four quarters, on average, was 17.67% for DXP Enterprises, 8.50% for Cintas and 4.01% for Chart Industries.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.

This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Danaher Corporation (DHR) : Free Stock Analysis Report
 
Cintas Corporation (CTAS) : Free Stock Analysis Report
 
Chart Industries, Inc. (GTLS) : Free Stock Analysis Report
 
DXP Enterprises, Inc. (DXPE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.